00721nam0-22002531i-450-990002733980403321000273398FED01000273398(Aleph)000273398FED0100027339820000920d1968----km-y0itay50------baENGExternal reporting for segments of a business.by Backer M. McFarlend W.B.New Yorks.e.1968Backer,Morton106856McFarland,Walter B.ITUNINARICAUNIMARCBK9900027339804033217-1-10s.i.ECAECAExternal reporting for segments of a business424584UNINAING0101861nam 2200325z- 450 991057171200332120231214133236.0(CKB)5860000000047225(oapen)https://directory.doabooks.org/handle/20.500.12854/83749(EXLCZ)99586000000004722520202206d2014 |y 0engurmn|---annantxtrdacontentcrdamediacrrdacarrierGender and the European UnionFlorenceFirenze University Press20141 electronic resource (78 p.)Strumenti per la didattica e la ricerca88-927-3446-6 Gender discrimination continues to be a reality in several parts of the world, also in Europe. The aim of this book is to provide an overview of both European Union’s (EU) gender policies and gender balance in EU institutions. It does so by looking at gender equality policies and the EU legal system concerning gender equality, women’s representation within diff erent institutions (and more particularly in the European External Action Service), gender rights as a type of human rights and the EU’s role in the external promotion of womens’ rights in third countries. The analysis shows that women’s representation in the EU institutions has increased in the last decades and that the EU has strengthened its att ention to gender rights in its external relations as well, however the results of both att empts are far from being fully satisfactory.Political science & theorybicsscPolitical science & theoryLUCARELLI SONIAedt148879LUCARELLI SONIAothBOOK9910571712003321Gender and the European Union3036466UNINA02526nam 2200589 a 450 991096921660332120200520144314.097816080529741608052974(CKB)2670000000148694(EBL)864207(OCoLC)779141401(SSID)ssj0000942934(PQKBManifestationID)11492225(PQKBTitleCode)TC0000942934(PQKBWorkID)10976890(PQKB)11670260(OCoLC)785783102(MiAaPQ)EBC864207(DE-B1597)731336(DE-B1597)9781608052974(EXLCZ)99267000000014869420120315d2012 uy 0engur|n|---|||||txtccrMultiple myeloma a new era of treatment strategies /editors, Klaus Podar, Kenneth C. Anderson1st ed.[U.S.A.] Bentham Science Publishers[2012]1 online resource (217 p.)Description based upon print version of record.9781608056095 1608056090 Includes bibliographical references and index.section 1. Multiple myeloma -- section 2. Treatment guidelines -- section 3. The bone marrow microenvironment and the pathogenesis of multiple myeloma -- section 4. New treatment strategies.Multiple Myeloma (MM), the second most common blood cancer in adults, is a clonal plasma cell malignancy within the bone marrow characterized by osteolytic bone lesions, renal disease, and immunodeficiency. It is now well established that MM cell- induced disruption of the bone marrow homeostasis between the highly organized cellular and extracellular compartments supports MM cell proliferation, survival, migration, and drug resistance via activation of various signaling pathways. Based on this knowledge, the prototypic drugs thalidomide, bortezomib, and lenalidomide, which target both MM cellMultiple myelomaTreatmentMultiple myelomaTreatment.616.99/418616.99418Podar Klaus, authttp://id.loc.gov/vocabulary/relators/aut1800395Podar Klaus1800395Anderson Kenneth C876632MiAaPQMiAaPQMiAaPQBOOK9910969216603321Multiple myeloma4345157UNINA